Trial Search Results

Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer

The purpose of this study is to determine if trastuzumab (Herceptin) increases disease-free survival when combined with radiation plus chemotherapy followed by surgery for patients with HER2-overexpressing esophageal adenocarcinoma.

Stanford is currently not accepting patients for this trial.

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
CCTO
650-498-7061
Not Recruiting